- AustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Inpixon Prices $9 Million Public Offering in an Effort to Satisfy Nasdaq’s Stockholders’ Equity Requirement
Inpixon (NASDAQ:INPX), a leading data analytics company announced the pricing of a public offering with anticipated gross proceeds of $9 million. As quoted in the press release: The securities offered by the Company consist of Units, at a price to the public of $1,000 per Unit, consisting of one share of the Company’s Series 4 …
Inpixon (NASDAQ:INPX), a leading data analytics company announced the pricing of a public offering with anticipated gross proceeds of $9 million.
As quoted in the press release:
The securities offered by the Company consist of Units, at a price to the public of $1,000 per Unit, consisting of one share of the Company’s Series 4 Convertible Preferred Stock, each convertible into approximately 2,174 shares of common stock at a conversion price of $0.46 and a warrant to purchase 2,174 shares of common stock. The warrants will have an exercise price of $0.67 (subject to adjustment to the exercise price and the number of warrant shares in the event of recapitalization events, stock dividends, stock splits, stock combinations, dilutive issuances, reclassifications, reorganizations, or similar events), will be exercisable upon issuance and will expire five years from the date of issuance. The offering is expected to close on or about April 24, 2018, subject to customary closing conditions. In addition, the Company may issue an additional $1.5 million in Units to debtholders to satisfy trade payables.
Inpixon’s common stock is listed on the NASDAQ Capital Market under the symbol “INPX”. The Company is conducting the offering in order to regain compliance with Nasdaq Listing Rule 5550(b)(1), which requires that listed companies maintain a minimum of $2.5 million in stockholders’ equity. The Company expects to use the net proceeds of the offering for working capital and general corporate purposes (including research and development, sales and marketing, and the satisfaction of outstanding amounts payable to vendors in connection with trade payables) and transaction expenses.
Roth Capital Partners is acting as the sole placement agent for the offering on a “best efforts” basis.
The securities are being offered pursuant to an effective shelf registration statement on Form S-3, as amended (File No. 333-204159), that was previously filed with the Securities and Exchange Commission (“SEC”) and declared effective on May 28, 2015. The securities may be offered only by means of a prospectus.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.